HIV感染症の疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
2.3 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 10
3.3 Global Trends 12
3.3.1 US 13
3.3.2 5EU 13
3.3.3 Brazil, China, and Japan 15
3.4 Forecast Methodology 15
3.4.1 Sources Used 16
3.4.2 Sources Not Used 26
3.4.3 Forecast Assumptions and Methods 27
3.5 Epidemiological Forecast for HIV in the 8MM (2013-2023) 33
3.5.1 Total Prevalent Cases of HIV 33
3.5.2 Age-Specific Total Prevalent Cases of HIV 36
3.5.3 Sex-Specific Total Prevalent Cases of HIV 37
3.5.4 Age-Standardized Total Prevalence of HIV 39
3.5.5 HIV Cases Treated with ART 40
3.5.6 Cases of HIV in Pregnant Women 42
3.6 Epidemiological Forecast for HIV in Japan (2013-2023) 43
3.6.1 20-Year Diagnosed Prevalent Cases of HIV 43
3.6.2 Age-Specific 20-Year Diagnosed Prevalent Cases of HIV 44
3.6.3 Sex-Specific 20-Year Diagnosed Prevalent Cases of HIV 45
3.6.4 Age-Standardized 20-Year Diagnosed Prevalence of HIV 46
3.6.5 HIV Cases Treated with ART 46
3.6.6 Cases of HIV in Pregnant Women 47
3.7 Discussion 48
3.7.1 Epidemiological Forecast Insight 48
3.7.2 Limitations of the Analysis 49
3.7.3 Strengths of the Analysis 50
4 Appendix 51
4.1 Bibliography 51
4.2 Physicians and Specialists Included in this Study 57
4.3 Primary Research – Prescriber Survey 59
4.4 About the Authors 60
4.4.1 Epidemiologists 60
4.4.2 Reviewers 61
4.4.3 Global Director of Therapy Analysis and Epidemiology 62
4.4.4 Global Head of Healthcare 62
4.5 About GlobalData 63
4.6 About EpiCast 63
4.7 Disclaimer 64